 antibody management colorectal cancer Results multicenter clinical study Presurgical colorectal cancer patients single intravenous infusions mg OncoScint immunoconjugate monoclonal antibody gamma camera imaging patients underwent operative procedure primary recurrent colorectal carcinoma patient recurrence colorectal cancer second primary malignancy small cell lung patients demonstrable evidence malignancy immunoscintigraphic findings consistent pathologic patients colorectal cancer disease-free patients Antibody surgical decision detection occult disease patients confirmation resectable disease regional metastatic spread patients adverse effects fevers itching patients developed antibodies immunoglobulin administration results study useful diagnostic tool presurgical evaluation colorectal cancer patients